Mitigation of Radiation-Induced Lung Injury in the Dog Model
Mitigation of Radiation-Induced Lung Injury in the Dog Model
批准号:
8083495
负责人:
RICHARD A. NASH
金额:
$1.49万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-15 至 2011-09-30
关键词:
Adenosine A2A ReceptorAgonistAlveolarAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryApoptoticApplications GrantsBone MarrowCanis familiarisCellsDevelopmentDoseEpithelial CellsExposure toGoalsInflammatoryInjuryIonizing radiationIschemiaLeadLungMesenchymal Stem CellsModelingNuclear WeaponProbabilityPulmonary FibrosisPurinergic P1 ReceptorsRadiationRadiation PneumonitisRadioactiveReperfusion TherapyReportingResearchRodentSafetySignal TransductionSourceStructure of parenchyma of lungTestingTissuesWhole-Body Irradiationalveolar type II cellclinically relevantcytokinedirty bombinjuredkeratinocyte growth factorlung injurymigrationpre-clinicalpreclinical studyradiation effectreconstitution
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Radiation pneumonitis after intentional or accidental exposure to a radioactive source, is associated with damage or loss of lung endothelial and epithelial cells, the release of cytokines, an accumulation of inflammatory cells within the alveolar spaces, and later, pulmonary fibrosis. It is the goal of this grant proposal to investigate approaches to mitigate radiation-induced lung injury in a large animal model. The agents selected for the study will have different putative mechanisms for mitigating the effect of the ionizing radiation on the lungs. In aim 1, we will determine the local dose of radiation to the lung which predictably induces radiation pneumonitis when administered in combination with total body irradiation. In aim 2, we will evaluate the effect of the study agents at the dose of radiation predicted to induce lung injury in aim 1. First, we will investigate the effect of keratinocyte growth factor (KGF) otherwise known as palifermin on the development of radiation pneumonitis. KGF stimulates type II pneumocytes and in rodents is protective for the lungs after radiation exposure and in other lung injury models. We will then assess the effect of primary bone marrow-derived mesenchymal stem cells (BM-MSC) on the development of radiation pneumonitis. It has been reported that MSC have directed migration to injured tissue and have mitigated tissue injury in models of ischemia or ischemia-reperfusion. MSC are immunomodulatory and may also contribute to the reconstitution of injured lung tissue. Finally, A2A adenosine receptor (AR) agonists will be tested. AR agonists have been shown to induce anti-apoptotic signals in tissue injury models and are anti-inflammatory. In aim 3, the study agent found to be most effective in aim 2 will be tested at an increased dose of radiation to the lung. Preclinical development of effective strategies for the mitigation of radiation-induced lung injury in a large animal model will increase the probability of successful treatment of victims exposed to ionizing radiation from a nuclear weapon or a 'dirty bomb'.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nonmyeloablative Hematopoietic Cell Transplantation for Severe Systemic Sclerosis
-
批准号:7111390
-
项目类别:
-
资助金额:$33.02万
-
财政年份:2006
-
负责人:RICHARD A. NASH
-
依托单位:
Lung Transplantation and Immune Tolerance in Young Recipients
-
批准号:7244124
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2006
-
负责人:RICHARD A. NASH
-
依托单位:
Lung Transplantation and Immune Tolerance in Young Recipients
-
批准号:7116022
-
项目类别:
-
资助金额:$25.95万
-
财政年份:2006
-
负责人:RICHARD A. NASH
-
依托单位:
ENGRAFTING SENSITIZED HOSTS WITH NONABLATIVE REGIMENS
-
批准号:2908630
-
项目类别:
-
资助金额:$43.25万
-
财政年份:1999
-
负责人:RICHARD A. NASH
-
依托单位:
ENGRAFTING SENSITIZED HOSTS WITH NONABLATIVE REGIMENS
-
批准号:6183983
-
项目类别:
-
资助金额:$43.25万
-
财政年份:1999
-
负责人:RICHARD A. NASH
-
依托单位:
ENGRAFTING SENSITIZED HOSTS WITH NONABLATIVE REGIMENS
-
批准号:6390531
-
项目类别:
-
资助金额:$43.25万
-
财政年份:1999
-
负责人:RICHARD A. NASH
-
依托单位:
ENGRAFTING SENSITIZED HOSTS WITH NONABLATIVE REGIMENS
-
批准号:6527225
-
项目类别:
-
资助金额:$43.25万
-
财政年份:1999
-
负责人:RICHARD A. NASH
-
依托单位:
Protection from GVHD with Gene-Modified Donor T Cells
-
批准号:7213422
-
项目类别:
-
资助金额:$38.55万
-
财政年份:1990
-
负责人:RICHARD A. NASH
-
依托单位:
Protection from GVHD with Gene-Modified Donor T Cells
-
批准号:6885349
-
项目类别:
-
资助金额:$40.66万
-
财政年份:1990
-
负责人:RICHARD A. NASH
-
依托单位:
Protection from GVHD with Gene-Modified Donor T Cells
-
批准号:7385000
-
项目类别:
-
资助金额:$37.78万
-
财政年份:1990
-
负责人:RICHARD A. NASH
-
依托单位:
HEMATOPOIETIC GROWTH FACTORS IN A CANINE STEM CELL MODEL
-
批准号:6791452
-
项目类别:
-
资助金额:$16.94万
-
财政年份:1990
-
负责人:RICHARD A. NASH
-
依托单位:
Protection from GVHD with Gene-Modified Donor T Cells
-
批准号:6729413
-
项目类别:
-
资助金额:$40.66万
-
财政年份:1990
-
负责人:RICHARD A. NASH
-
依托单位:
Protection from GVHD with Gene-Modified Donor T Cells
-
批准号:7054150
-
项目类别:
-
资助金额:$39.7万
-
财政年份:1990
-
负责人:RICHARD A. NASH
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: